Secondary hyperparathyroidism is a frequent complication of patients with chronic kidney disease and is characterized by excessive serum parathyroid hormone levels and an imbalance in calcium and phosphorus metabolism.
Introduction
The term renal osteodystrophy represents a variety of bone disorders caused by chronic renal failure (CRF). Renal osteodystrophy is sometimes called "the silent crippler"; affected patients may be completely asymptomatic. Symptoms, including bone and joint pain and bone deformation and fractures, are more frequent during the late stages of the disease. The most common abnormality is the Osteitis Fibrosa Cystica, with extensive bone marrow fibrosis and increased osteoclastic bone resorption. 5 It is a reparative cellular process, rather than a neoplastic process. These lesions are termed "Brown Tumour" due to the presence of old hemorrhage in the lesion and its reddish color.
Bone resorption occurs because of increased osteoclastic activity and affects all bone surfaces at different skeletal sites. It may be subperiosteal, intracortical, endosteal, trabecular, subchondral, subligamentous or subtendinous. 6 Fragility fractures sometimes occur at the sites of brown tumors. These lesions are caused by rapid osteoclastic activity and peritrabecular fibrosis, and are usually well-defined purely lytic lesions with the cortex thinned and expanded but not penetrated. Since they are usually painless, the clinical diagnosis is commonly made when the patient presents a fracture. Brown tumors appear mostly at the pelvis, ribs, clavicles, mandible and extremities. 
Discussion
Evidence suggests that the alterations in serum PTH and mineral metabolism in SHPT have important consequences for haemodialysis patients. Increased calcium and phosphorus concentrations are key contributors to SHPT-associated all-cause and cardiovascular (CV) mortality and bone disease.
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Osteitis fibrosa cystica was first described in the nineteenth century by von Recklinghausen; it presents as the end stage findings of hyperparathyroidism.
However recently, with the technical development of imaging and laboratory screening methods, hypercalcemia due to primary or secondary hyperparathyroidism can often be detected early; as a result the frequency of osteitis fibrosa cystica has declined.
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However, it is not a true neoplasm but rather a reactive osteolytic lesion of bone and may mimic other diseases such as giant cell tumors, multiple bone metastasis or multiple myeloma.
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Osteitis fibrosa cystica appears as a well-defined expansile osteolytic lesion with osteopenia on plain radiographs, and as a well enhanced mass on CT and MRI T2-weighted imaging, and is isodense on T1-weighted images. 
